Biotech · Private company
Imbrium Therapeutics
Track this companyFree. Adds Imbrium Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- V117957 tabletsPhase 2 · InsomniaClinicalTrials.gov · fetched Nov 12, 2026
- V117957Phase 1 · Interstitial Cystitis/Bladder Pain SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- V117957Phase 1 · Overactive Bladder SyndromeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Study of Sunobinop on Craving in Alcohol Use DisorderPHASE2 · COMPLETED · started Jan 28, 2025ClinicalTrials.gov NCT06545929 · fetched Nov 12, 2026
- Study of Sunobinop on Alcohol Consumption in Alcohol Use DisorderPHASE2 · COMPLETED · started Oct 14, 2024ClinicalTrials.gov NCT06545916 · fetched Nov 12, 2026
- Study of V117957 in Overactive Bladder SyndromePHASE1 · COMPLETED · started Jun 30, 2022ClinicalTrials.gov NCT06024642 · fetched Nov 12, 2026
- Study of V117957 in Interstitial Cystitis/Bladder Pain SyndromePHASE1 · COMPLETED · started May 26, 2022ClinicalTrials.gov NCT06285214 · fetched Nov 12, 2026
- Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol CessationPHASE2 · COMPLETED · started Sep 23, 2019ClinicalTrials.gov NCT04035200 · fetched Nov 12, 2026